Avoid False Positive Data: Improve Performance with the R&D Systems™ Quantikine™ Assays

Enzyme Linked Immunosorbent Assays (ELISAs) are commonly used to quantify biomarkers in complex sample types such as serum and plasma. A variety of factors present in these samples can interfere with ELISA results, and these matrix effects, along with non-specific binding to the microplate, can lead to false positive data. Download this application note to see how the proprietary blocking reagents used in R&D Systems Quantikine Assays eliminate non-specific binding and matrix effects that lead to false positive data in samples quantified using other commercially available ELISAs.